Foyou Pharma has obtained the approval notice for the listing application of Clobazam raw materials
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Foyou Pharma announced that it has recently received the "Approval Notice for the Market Application of Chemical Raw Materials" for Clobetasol from the National Medical Products Administration. Clobetasol is suitable for topical treatment of mild to moderate atopic dermatitis in patients aged 2 years and older. The company's acquisition of the "Approval Notice for the Market Application of Chemical Raw Materials" for Clobetasol will further enrich the company's product line and promote its continuous, stable, and healthy development
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments